Pappalysin 2 (PAPP-A2) Enzyme Replacement

Clinical trial NCT02412943 · COMPLETED

Trial details

NCT number: NCT02412943
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Short Stature, Idiopathic

Start date: 2015-04-01
Primary completion: 2015-05-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.